Why David Einhorn’s Greenlight prefers this tiny biotech over AI ‘excitement’
Up next
Author


Greenlight Capital’s third-quarter investor letter had almost nothing good to say about the hot AI trend, but it does have faith in a tiny biotech.

You May Also Like
Jobless claims — and layoffs — are still low. Unofficially, that is.

Jobless claims — and layoffs — are still low. Unofficially, that is.

The weekly jobless claims report won’t resume until the government shutdown, which…

Treasury yields end with largest weekly declines since November ahead of Trump’s inauguration

Yields on U.S. government debt finished higher on Friday as traders weighed…

Starmer pledges ‘action’ against ‘extremists’ as police face fresh unrest

Sir Keir Starmer has warned that “violence committed by a small minority…
Stock market’s records belie the crack forming beneath the surface

Stock market’s records belie the crack forming beneath the surface

The S&P 500 and Nasdaq Composite both claimed record highs this week.…